The menstrual cycle consists of four distinct phases spanning an average of 28 days, though normal cycles range from 21 to 35 days. The follicular phase lasts 14 days with estrogen rising from 30 to 100 pg/mL. Ovulation occurs around day 14 when luteinizing hormone peaks at 25-40 IU/L, followed by the luteal phase where progesterone climbs to 5-20 ng/mL. The menstrual phase begins when both hormones drop to baseline levels, triggering the shedding of the endometrial lining. Each phase serves specific biological functions: follicular phase prepares eggs for release, ovulation releases the mature egg, luteal phase prepares for potential pregnancy, and menstruation clears the uterine lining when pregnancy doesn't occur. Understanding these hormonal fluctuations helps women track fertility, manage symptoms, and optimize health decisions throughout their reproductive years.
- Normal menstrual cycles range from 21-35 days with predictable hormone patterns
- Estrogen peaks during the follicular phase at 100-400 pg/mL before ovulation
- Progesterone dominates the luteal phase, reaching 5-20 ng/mL after ovulation
- LH surge triggers ovulation with levels jumping to 25-40 IU/L within 24 hours
- Hormone imbalances can be addressed through peptide therapy and lifestyle modifications
Follicular Phase: Preparing for Ovulation
The follicular phase begins on day 1 of menstruation and lasts approximately 14 days in a standard 28-day cycle. During this phase, follicle-stimulating hormone (FSH) levels rise to 3-20 IU/L, stimulating the ovaries to develop multiple follicles. Estrogen levels gradually increase from a baseline of 30 pg/mL to peak levels of 100-400 pg/mL just before ovulation.
This estrogen surge serves multiple purposes: it thickens the endometrial lining to prepare for potential implantation and stimulates the production of fertile cervical mucus. The rising estrogen also provides positive feedback to the brain, eventually triggering the luteinizing hormone surge that causes ovulation. Women often experience increased energy and mood during the late follicular phase due to rising estrogen levels.
Ovulation: The Hormonal Peak
Ovulation occurs when luteinizing hormone levels spike dramatically from baseline levels of 5-25 IU/L to peak concentrations of 25-40 IU/L within a 24-48 hour window. This LH surge causes the dominant follicle to release its mature egg, typically occurring around day 14 of the cycle. Estrogen reaches its monthly peak just before ovulation, often exceeding 200 pg/mL in healthy women.
View data table
| Category | Symptom Improvement (%) | Detail |
|---|---|---|
| Week 2 | 30 | Mood stabilization begins |
| Month 1 | 50 | Hot flash reduction |
| Month 3 | 72 | Significant symptom relief |
| Month 6 | 88 | Full therapeutic benefit |
The ovulatory phase also marks the beginning of progesterone production, though levels remain relatively low at 1-3 ng/mL during this time. Many women can identify ovulation through physical signs including a slight temperature rise, changes in cervical mucus consistency, and mild pelvic pain. Some patients exploring hormonal optimization find that Sermorelin therapy can support overall endocrine function during this critical phase.
Luteal Phase: Progesterone Dominance
The luteal phase spans from ovulation to the start of the next menstrual period, typically lasting 12-14 days. After ovulation, the empty follicle transforms into the corpus luteum, which produces substantial amounts of progesterone. Progesterone levels rise dramatically from 1-3 ng/mL during ovulation to peak levels of 5-20 ng/mL during the mid-luteal phase.
Personalized hormone therapy for women
Work with a licensed provider to find the right hormone optimization plan for your symptoms and goals.
Start Free Assessment →This progesterone surge stabilizes the endometrial lining and creates an environment conducive to embryo implantation. Estrogen levels remain moderately elevated during the early luteal phase but gradually decline if pregnancy doesn't occur. The luteal phase length remains relatively consistent across different women, unlike the follicular phase which can vary significantly. Some women experience luteal phase deficiency, where progesterone levels remain inadequately low, potentially affecting fertility and causing irregular bleeding.
Menstrual Phase: Hormonal Reset
The menstrual phase begins when progesterone and estrogen levels drop to their lowest points, typically falling below 5 ng/mL and 50 pg/mL respectively. This hormonal withdrawal triggers the shedding of the endometrial lining, resulting in menstrual flow that lasts 3-7 days for most women. The average blood loss during menstruation ranges from 30-40 mL, though normal volumes can vary from 5-80 mL.
During menstruation, FSH levels begin to rise again, initiating the development of new follicles for the next cycle. This phase often coincides with the lowest energy levels of the month due to minimal hormone production. Women experiencing significant hormonal imbalances may benefit from treatments like BPC-157 for tissue repair and regeneration, particularly if they experience heavy or painful periods that affect quality of life.
Frequently Asked Questions
What are normal hormone levels during each menstrual cycle phase?
Normal hormone levels vary by phase: follicular phase estrogen ranges from 30-100 pg/mL, ovulation peaks at 200-400 pg/mL estrogen with LH surging to 25-40 IU/L, luteal phase progesterone reaches 5-20 ng/mL, and menstrual phase shows both hormones at baseline levels below 50 pg/mL for estrogen and 5 ng/mL for progesterone. Individual variations are common and depend on age, health status, and cycle length.
How long should each phase of the menstrual cycle last?
A typical 28-day cycle includes a follicular phase of 10-16 days, ovulation lasting 12-24 hours, luteal phase of 12-14 days, and menstruation for 3-7 days. The luteal phase remains relatively consistent, while the follicular phase can vary significantly between women and cycles. Normal total cycle length ranges from 21-35 days, with most women maintaining consistent patterns within this range.
Can hormone imbalances affect menstrual cycle phases?
Yes, hormone imbalances can significantly disrupt normal menstrual cycle phases. Low progesterone can shorten the luteal phase, high androgens may prevent ovulation, and thyroid disorders can lengthen or shorten cycles unpredictably. PCOS affects up to 10% of reproductive-age women and commonly causes irregular ovulation. Treatment options in 2026 include lifestyle modifications, hormonal therapy, and emerging peptide treatments that support natural hormone production.
What symptoms indicate healthy menstrual cycle phases?
Healthy menstrual cycles typically include predictable timing within 21-35 days, moderate flow lasting 3-7 days, minimal cramping that doesn't interfere with daily activities, and clear ovulation signs like fertile cervical mucus and slight temperature rise. Energy levels often fluctuate predictably with rising during the follicular phase and dipping during menstruation. Severe pain, extremely heavy bleeding, or cycles shorter than 21 days or longer than 35 days warrant medical evaluation.
How do birth control methods affect natural menstrual cycle phases?
Hormonal birth control methods suppress natural menstrual cycle phases by providing synthetic hormones that prevent ovulation. Combined pills maintain steady hormone levels, eliminating the natural fluctuations between phases. Progestin-only methods may allow some ovarian function while irregular bleeding patterns. IUDs affect cycles differently, with hormonal types often reducing flow while copper IUDs may increase it. Natural cycle phases typically resume within 3-6 months after discontinuing hormonal contraception.
Sources
- Reed BG, Carr BR. The Normal Menstrual Cycle and the Control of Ovulation. Endotext. 2018. PMID: 25905282
- Mihm M, Gangooly S, Muttukrishna S. The normal menstrual cycle in women. Anim Reprod Sci. 2011;124(3-4):229-236. PMID: 20869180
- Critchley HO, Babayev E, Bulun SE, et al. Menstruation: science and society. Am J Obstet Gynecol. 2020;223(5):624-664. PMID: 32707071
- Jain A, Polotsky AJ, Rochester D, et al. Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J Clin Endocrinol Metab. 2007;92(7):2468-2473. PMID: 17440019
- Santoro N, Roeca C, Peters BA, Neal-Perry G. The Menopause Transition: Signs, Symptoms, and Management Options. J Clin Endocrinol Metab. 2021;106(1):1-15. PMID: 33095879
- Fraser IS, Critchley HO, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011;29(5):383-390. PMID: 22065325
- McNamara M, Batur P, DeSapri KT. In the clinic. Perimenopause. Ann Intern Med. 2015;162(3):ITC1-15. PMID: 25560724